Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Multiple Myeloma 74 Recurrence 11 Neoplasms, Plasma Cell 6 Waldenstrom Macroglobulinemia 2 Neoplasms 2 Plasmacytoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Leukemia, Plasma Cell 1 Leukemia 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 43 venetoclax 30 Cytarabine 25 fludarabine 22 fludarabine phosphate 17 Azacitidine 16 Mycophenolic Acid 13 Whole-Body Irradiation 12 Dexamethasone 12 Rituximab 11 Busulfan 11 ruxolitinib 10 Vincristine 10 Methotrexate 10 Etoposide 10 Tacrolimus 9 Mercaptopurine 9 Daunorubicin 9 Prednisone 8 Filgrastim 8 Dasatinib 8 ibrutinib 7 Peripheral Blood Stem Cell Transplantation 7 Melphalan 7 Granulocyte Colony-Stimulating Factor 7 Doxorubicin 7 Decitabine 7 pegaspargase 6 blinatumomab 6 Mesna 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia × carfilzomib × 1 year × Clear all

NCT02512926 2025-10-15

POE14-01

Stanford University

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡